Evaluation of Methods for Measuring Gastrointestinal Transit and Food Reward in Healthy Individuals - The PRESET Study
PRESET
1 other identifier
interventional
15
1 country
1
Brief Summary
The wireless motility capsule technology, SmartPill™, can be used to assess gastric emptying and gastrointestinal (GI) transit time. The SmartPill is usually ingested together with a SmartBar™ which is a snack bar with a nutrient composition that differs substantially from a normal western diet. The primary aim of the present study is to compare effects of a SmartBar™ and a standard mixed meal on gastric emptying and GI motility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2018
CompletedFirst Submitted
Initial submission to the registry
March 12, 2019
CompletedFirst Posted
Study publicly available on registry
March 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 24, 2019
CompletedJune 18, 2019
June 1, 2019
7 months
March 12, 2019
June 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gastric emptying time (minutes)
Measured by the SmartPill™ technique. The SmartPill™ is ingested at both visits in combination with the standard breakfast meal and SmartBar™, respectively. The time frame depends on the individual gastric emptying time.
Within 24 hours from ingestion of the SmartPill™ at both visits (standard breakfast meal and SmartBar™, respectively)
Secondary Outcomes (57)
Small bowel transit time (minutes)
Within 5 days after both visits (standard breakfast meal and SmartBar™, respectively)
Large bowel transit time (minutes)
Within 5 days after both visits (standard breakfast meal and SmartBar™, respectively)
Total gastrointestinal transit time (minutes)
Within 5 days after both visits (standard breakfast meal and SmartBar™, respectively)
Motility index (arbitrary unit)
Within 5 days after both visits (standard breakfast meal and SmartBar™, respectively)
Metabolites
0 minutes (fasting) and 15, 30, 45, 60, 90, 120, 180, 240 minutes (after consumption of the standard breakfast meal and SmartBar™, respectively)
- +52 more secondary outcomes
Study Arms (2)
SmartBar™
ACTIVE COMPARATORThe wireless capsule technology, SmartPill™, is usually ingested together with a SmartBar™ which is a snack bar with a nutrient composition that differs substantially from a normal western diet.
Standard mixed breakfast meal
EXPERIMENTALThe SmartPill™ is ingested together with a standard mixed breakfast meal and the outcomes of interest will be compared with the SmartBar™ condition (reference).
Interventions
The standard mixed breakfast meal consists of: 150 g yoghurt, 20 g muesli; 50 g wheat bun; 22 g rye bread; 25 g cheese; 25 g marmalade; 8 g butter; Total energy content: 500 kcal Macronutrient composition: 34 E% fat, 17 E% protein, 49 E% carbohydrate
SmarBar™ (Medtronic, North Haven, MA, USA). Weight: 72 g; Total energy content: 260 kcal Macronutrient composition: 7 E% fat, 19 E% protein, 74 E% carbohydrate.
Eligibility Criteria
You may qualify if:
- Body mass index: 18.5 to 24.9 kg/m2
You may not qualify if:
- Unable to understand the informed consent and the study procedures;
- Self-reported history of an eating disorder in the past three years
- HbA1c: ≥5.7 % (≥39 mmol/mol)
- Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, GI or psychiatric disease; diabetes or other endocrine disease; immunosuppression
- Current treatment with medication or medical devices which affect GI motility and transit time (prokinetics, antidiarrheals, laxatives)
- Current treatment with medication which affect glucose metabolism or appetite
- Current treatment with beta blockers or peroral steroids
- Current treatment with non-steroidal anti-inflammatory drugs, tricyclic antidepressants, selective serotonin re-uptake inhibitors or opioids
- Bariatric surgery
- GI symptoms or diseases such as regular (weekly) abdominal pain, dysphagia, gastric bezoars, strictures, fistulas, bowel obstructions, diverticulitis, celiac disease, Crohn's disease, ulcerative colitis or proctitis
- Pregnant or lactating women
- Fertile women not using birth control agents including oral contraceptives, gestagen injection, subdermal implants, hormonal vaginal ring, transdermal application, or intra-uterine devices
- Concomitant participation in other research studies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kristine Færchlead
- University of Copenhagencollaborator
- IMotions A/Scollaborator
- University of Leedscollaborator
- Aalborg University Hospitalcollaborator
Study Sites (1)
Steno Diabetes Center Copenhagen
Gentofte Municipality, DK-2810, Denmark
Related Publications (1)
Jensen MM, Pedersen HE, Clemmensen KKB, Ekblond TS, Ried-Larsen M, Faerch K, Brock C, Quist JS. Associations Between Physical Activity and Gastrointestinal Transit Times in People with Normal Weight, Overweight, and Obesity. J Nutr. 2024 Jan;154(1):41-48. doi: 10.1016/j.tjnut.2023.06.005. Epub 2023 Jun 12.
PMID: 37315794DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kristine Færch, PhD
Steno Diabetes Center Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Senior Researcher and Team Leader, PhD
Study Record Dates
First Submitted
March 12, 2019
First Posted
March 28, 2019
Study Start
October 16, 2018
Primary Completion
May 24, 2019
Study Completion
May 24, 2019
Last Updated
June 18, 2019
Record last verified: 2019-06